Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity

  1. Ríos-Luci, C.
  2. García-Alonso, S.
  3. Díaz-Rodríguez, E.
  4. Nadal-Serrano, M.
  5. Arribas, J.
  6. Ocaña, A.
  7. Pandiella, A.
Aldizkaria:
Cancer Research

ISSN: 1538-7445 0008-5472

Argitalpen urtea: 2017

Alea: 77

Zenbakia: 17

Orrialdeak: 4639-4651

Mota: Artikulua

DOI: 10.1158/0008-5472.CAN-16-3127 GOOGLE SCHOLAR lock_openSarbide irekia editor